Rainbow Childrens Medicare credit ratios

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

−438	−438	−591	−318	−104	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−0.26×	−0.26×	−0.40×	−0.25×	−0.10×
−0.76×	−0.81×	−1.21×	−0.74×	−0.26×
5.07×	5.07×	4.85×	5.36×	5.55×

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

RAINBOW₹1,196.80

Rainbow Childrens Medicare Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP FORTIS KIMS POLYMED PFIZER ONESOURCE JUBLPHARMA VIJAYAMcap ₹12,155 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Net Debt	-103.6	-317.6	-591.0	-438.4	-438.4
Net Debt/Equity	-0.10	-0.25	-0.40	-0.26	-0.26
Net Debt/EBITDA	-0.26	-0.74	-1.21	-0.81	-0.76
Interest Coverage (EBIT/Interest)	5.55	5.36	4.85	5.07	5.07

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.